Promoter holding
64.27%
AP
Avoxycoat Private Limited - Due diligence report
A 360° intelligence report on Avoxycoat Private Limited: trust score, financial health, credit view, compliance, directors, growth and distr…
AP
Avoxycoat Private Limited
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Avoxycoat Private Limited — 360° Intelligence Report
Generated from MCA filings & public records59/100
Trust Score
Moderate
Avoxycoat Private Limited is assessed as Moderate with a Trust Score of 59/100. Avoxycoat Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Avoxycoat Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
59/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
30/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
Charges position: 0 open (-) · 0 satisfied (-).
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2019 - filings overdue.
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIRENDRA JANRAO MANDAPE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AKASH SHANKAR SONTAKKE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- VIRENDRA JANRAO MANDAPE has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 50
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence63/100
Review suggested
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view41/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 7 events25 Nov 2020
Director appointed
VIRENDRA JANRAO MANDAPE (Director)
Director appointed
AKASH SHANKAR SONTAKKE (Director)
30 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
26 Jul 2013
Director ceased
VIBHA HARSHWARDHAN BORA
Director ceased
ATUL INDERCHAND KAKLIYA
03 Dec 2011
Incorporated
Registered with Roc Nagpur
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Doctor Poswal Foundation | U85100DL2012NPL241154 | Jasola Extn, Delhi, India |
| Qlinica Iq India (Opc) Private Limited | U93090KA2019OPC120827 | Hsr Layout, Karnataka, India |
| Neeveda Ayurcare Private Limited | U93000TN2014PTC095241 | Chennai, Tamil Nadu, India |
| Anwesha Women'S Care (Opc) Private Limited | U85300WB2018OPC224129 | Kolkata, West Bengal, India |
| Enhance Brandmark Private Limited | U74999PN2015PTC156258 | Pune, Maharashtra, India |
| Medicaso Solutions Private Limited | U74999MH2017PTC292919 | Mumbai, Maharashtra, India |
| Malayoram Ayurveda Hill Resorts Private Limited | U55102KL2000PTC014252 | Idukki, Kerala, India |
| Virescent World Private Limited | U74110JH2010PTC014568 | Ranchi, Jharkhand, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Avoxycoat Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Avoxycoat Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Avoxycoat Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 59/100, distress signals and MSME payment-delay disclosures - know whether Avoxycoat Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Avoxycoat Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Avoxycoat Private Limited an active company?
Avoxycoat Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Avoxycoat Private Limited financially healthy?
Avoxycoat Private Limited has a Financial Health Score of 30/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Avoxycoat Private Limited?
Its overall Trust Score is 59/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Avoxycoat Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Avoxycoat Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Avoxycoat Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Avoxycoat Private Limited?
Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
